Expression of CD44 isoforms in human skin cancer

European Journal of Cancer Part A

Volumn 32, Issue 8, 1996, Pages 1394-1400

  Simon, J C ^a   Heider, K H ^b   Dietrich, A ^a   Wuttig, C ^a   Schopf E ^a   Adolf, G R ^b   Ponta, H ^c   Herrlich, P ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Bender and Co GmbH   (Austria)

^c NONE

Author keywords

Basal cell carcinoma; CD44 isoforms; Malignant melanoma; Squamous cell carcinoma

Indexed keywords

CELL SURFACE PROTEIN; HERMES ANTIGEN;

ARTICLE; BASAL CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CANCER; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA;

EID: 0030037249     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00196-7     Document Type: Article

References (29)

1. Weinstock MA. Epidemiology of nonmelanoma skin cancer: clinical issues, definition, and classification. J Invest Dermatol 1994, 102, 4S-5S.
2. Balch CM, Houghton AN, Peters LJ. Cutaneous melanoma. In de Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology, 4th ed. J.B. Lippincott Co., Philadelphia, 1993, 1612-1661.
3. Rünger TM, Klein CE, Becker JC, Bröcker EB. The role of genetic instability, adhesion, cell motility, and immune escape mechanisms in melanoma progression. Curr Opin Oncol 1994, 6, 188-196.
4. East JA, Hart IR. CD44 and its role in tumour progression and metastasis. Eur J Cancer 1993, 29A, 1921-1922.
5. Herrlich P, Rudy P, Hofmann M, et al. CD44 and splice variants of CD44 in normal differentiation and tumor progression. In Hemler ME, Mihich E, eds. Cell Adhesion Molecules. New York, Plenum Press, 1994, 265-288.
6. Heider K-H, Hofmann M, Horst E, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993, 120, 227-233.
7. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992, 89, 12160-12164.
8. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65, 13-24.
9. Fox SB, Gatter KC, Jackson DG, et al. CD44 and cancer screening. Lancet 1993, 342, 548-549.
10. Mayer B, Jauch KW, Günthert U, et al. De novo expression of CD44 and survival in gastric cancer. Lancet 1993, 342, 1019-1022.
11. Wielenga VJM, Heider K-H, Offerhaus GJA, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993, 53, 4754-4756.
12. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995, 345, 615-619.
13. Mulder JW, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994, 344, 1470-1472.
14. Koopman G, Heider K-H, Horst E, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993, 177, 897-904.
15. Abbasi AM, Chester KA, Talbot IC, et al. CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur J Cancer 1993, 29A, 1995-2002.
16. Dali P, Heider K-H, Hekele A, et al. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 1994, 54, 3337-3341.
17. Heider K-H, Dämmrich J, Skroch-Angel P, et al. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993, 53, 4197-4203.
18. Denfeld RW, Dietrich A, Wuttig C, et al. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T cell-mediated antitumor immunity. Int J Cancer 1995, 62, 259-265.
19. Hofmann M, Rudy W, Zoeller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991, 51, 5292-5297.
20. Stamenkovic I, Amlot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989, 56, 1057-1062.
21. Allen RW, Trach KA, Hoch JA. Identification of the 37 kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1987, 262, 649-652.
22. Kugelman LC, Ganguly S, Haggerty JG, Weissman SM, Milstone LM. The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44. J Invest Dermatol 1992, 99, 381-385.
23. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993, 122, 431-442.
24. Manten-Horst E, Danen EH, Smit L, et al. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 1995, 64, 182-188.
25. Moretti S, Martini L, Berti E, Prinzi C, Gianotti B. Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res 1993, 3, 235-239.
26. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D. CD44H expression by neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 1994, 54, 4238-4242.
27. Favrot MC, Combaret V, Lasset C, Bérard CL. CD44 - a new prognostic marker for neuroblastoma. Lancet 1993, 329, 1965-1970.
28. Shtivelman E, Bishop M. Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 1991, 11, 5446-5453.
29. Sherman L, Skroch-Angel P, Moll J, et al. Schwann cell tumors express characteristic patterns of CD44 splice variants. J Neuro-Oncology 1995, 26, 171-184.